Although they primarily focused on demonstrating that exogenous BCL-xL controls several hallmarks of cancer aggressiveness such as migration, invasion and tumor cell plasticity, both in GBM and melanoma, these authors also noted that BCL-xL overexpression positively regulated the cancer stem cell phenotype in tumorspheres compared to control cells [21]. This evidence concerns the gene BCL2L1 and neoplasm.